Literature DB >> 6232278

The structure of mammalian small nuclear ribonucleoproteins. Identification of multiple protein components reactive with anti-(U1)ribonucleoprotein and anti-Sm autoantibodies.

I Pettersson, M Hinterberger, T Mimori, E Gottlieb, J A Steitz.   

Abstract

The Sm small nuclear ribonucleoproteins (snRNPs) from mammalian cells have been characterized as containing U1, U2, U4, U5, and U6 RNA associated with some subset of at least 10 distinct polypeptides (called 68K, A, A', B, B', C, D, E, F, and G) that range in molecular weight from 68,000 to 11,000. Whereas this entire collection of snRNP particles is precipitated by patient anti-Sm autoantibodies, anti-(U1)RNP autoantibodies specifically recognize U1 snRNPs. Here, we have performed immunoblots using the sera from 29 patients and a mouse anti-Sm monoclonal antibody to identify which HeLa cell snRNP proteins carry anti-Sm or anti-(U1)RNP antigenic determinants. Strikingly, every serum surveyed, as well as the monoclonal antibody, recognizes determinants on two or more snRNP protein components. The three proteins, 68K, A, and C, that uniquely fractionate with U1 snRNPs are specifically reactive with anti-(U1)RNP sera in blots. Anti-Sm patient sera and the mouse monoclonal antibody react with proteins B, B', D, and sometimes E, one or more of which must be present on all Sm snRNPs. The blot results combined with data obtained from a refined 32P-labeled RNA immunoprecipitation assay reveal that, in our collection of the sera from 29 patients, anti-Sm rarely exists in the absence of equal or higher titers of anti-(U1)RNP; moreover, (U1)RNP sera often contain detectable levels of anti-Sm. Our findings further define the protein composition of the Sm snRNPs and raise intriguing questions concerning the relatedness of snRNP polypeptides and the mechanism of autoantibody induction.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6232278

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  137 in total

1.  A role for the GSG domain in localizing Sam68 to novel nuclear structures in cancer cell lines.

Authors:  T Chen; F M Boisvert; D P Bazett-Jones; S Richard
Journal:  Mol Biol Cell       Date:  1999-09       Impact factor: 4.138

2.  Association of human DEAD box protein DDX1 with a cleavage stimulation factor involved in 3'-end processing of pre-MRNA.

Authors:  S Bléoo; X Sun; M J Hendzel; J M Rowe; M Packer; R Godbout
Journal:  Mol Biol Cell       Date:  2001-10       Impact factor: 4.138

3.  Evidence for a posttranscriptional role of a TFIIICalpha-like protein in Chironomus tentans.

Authors:  Nafiseh Sabri; Ann-Kristin Ostlund Farrants; Ulf Hellman; Neus Visa
Journal:  Mol Biol Cell       Date:  2002-05       Impact factor: 4.138

4.  Viral transcription is necessary and sufficient for vesicular stomatitis virus to inhibit maturation of small nuclear ribonucleoproteins.

Authors:  D E Crone; J D Keene
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

Review 5.  B-cell epitopes of Sm autoantigens.

Authors:  L A Rokeach; S O Hoch
Journal:  Mol Biol Rep       Date:  1992-06       Impact factor: 2.316

Review 6.  Anti-Sm autoantibodies in systemic lupus erythematosus mice: a model system for disease-specific autoreactivity.

Authors:  R A Eisenberg
Journal:  Springer Semin Immunopathol       Date:  1992

7.  Heterogeneity of RNP and Sm autoantigens in relation to the cell sources and the activated state of the cells.

Authors:  F Hiepe; K Yamamoto; A Takeuchi; E Apostoloff; T Miyamoto
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

8.  U1 small nuclear ribonucleoprotein particle-specific proteins interact with the first and second stem-loops of U1 RNA, with the A protein binding directly to the RNA independently of the 70K and Sm proteins.

Authors:  J R Patton; W Habets; W J van Venrooij; T Pederson
Journal:  Mol Cell Biol       Date:  1989-08       Impact factor: 4.272

9.  Clinical significance of anti-RNP and anti-Sm autoantibodies as determined by immunoblotting and immunoprecipitation in sera from patients with connective tissue diseases.

Authors:  B Combe; M Rucheton; H Graafland; V Lussiez; C Brunel; J Sany
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

10.  Stochastic control of anti-Sm autoantibodies in MRL/Mp-lpr/lpr mice.

Authors:  R A Eisenberg; S Y Craven; R W Warren; P L Cohen
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.